 Disodium pamidronate preoperative treatment hypercalcemia patients primary hyperparathyroidism Nine patients median age years primary hyperparathyroidism intravenous infusions disodium pamidronate APD bisphosphonate drug patients severe hypercalcemia serum calcium concentration mmol/L persisting rehydration saline treatment furosemide patients moderate hypercalcemia pronounced symptoms serum calcium concentration mmol/L patients hypercalcemic crises patients serum calcium levels disodium pamidronate infusions week single infusion mg disodium pamidronate patients serum calcium concentrations normal reference interval patients values Transient asymptomatic hypocalcemia patient patients infusions side effects patients verified parathyroid adenomas temporary increase parathyroid hormone levels concomitant drop serum calcium level patient parathyroid cancer effect autonomous parathyroid hormone secretion parathyroid carcinoma tumor good effect treatment osteoclast inhibitor disodium pamidronate hypercalcemia primary hyperparathyroidism hypercalcemia due osteoclast activity number patients series small general conclusions case series show disodium pamidronate promises value different clinical situations treatment severe hypercalcemia patients hyperparathyroidism patient symptoms hypercalcemia treatment hypercalcemic crises diuresis serum calcium unsuccessful parathyroid surgery long-term treatment reoperation time localization studies healing scar reaction fragile patients alternative surgery